Registered number
10755143
UDC Health Limited
Report and Accounts
30 June 2024
UDC Health Limited
Registered number: 10755143
Director's Report
The director presents his report and accounts for the year ended 30 June 2024.
Principal activities
The company's principal activity during the year continued to be health tourism.
Directors
The following persons served as directors during the year:
Mr Basri Yilmaz
Small company provisions
This report has been prepared in accordance with the provisions in Part 15 of the Companies Act 2006 applicable to companies subject to the small companies regime.
This report was approved by the board on 5 November 2024 and signed on its behalf.
Mr Basri Yilmaz
Director
UDC Health Limited
Accountants' Report
Accountants' report to the director of
UDC Health Limited
You consider that the company is exempt from an audit for the year ended 30 June 2024. You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Dirench & Co
Accountants
151 West Green Road
LONDON
N15 5EA
5 November 2024
UDC Health Limited
Profit and Loss Account
for the year ended 30 June 2024
Notes2024 2023
£ £
Turnover70,85372,240
Administrative expenses(41,397)(42,959)
Operating profit29,45629,281
Loss on the disposal of investments(49,500)-
Interest payable(368)(769)
(Loss)/profit on ordinary activities before taxation(20,412)28,512
Tax on (loss)/profit on ordinary activities- (5,417)
(Loss)/profit for the financial year(20,412)23,095
UDC Health Limited
Registered number:10755143
Balance Sheet
as at 30 June 2024
Notes2024 2023
£ £
Fixed assets
Tangible assets335,548923
Investments- 55,010
35,54855,933
Current assets
Debtors424,5079,620
Cash at bank and in hand3,6811,246
28,18810,866
Creditors: amounts falling due within one year5(30,000)(10,547)
Net current (liabilities)/assets(1,812)319
Total assets less current liabilities33,73656,252
Creditors: amounts falling due after more than one year6(28,351)(30,455)
Net assets5,38525,797
Capital and reserves
Called up share capital11
Profit and loss account5,38425,796
Shareholder's funds5,38525,797
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Basri Yilmaz
Director
Approved by the board on 5 November 2024
UDC Health Limited
Statement of Changes in Equity
for the year ended 30 June 2024
ShareShareRe-ProfitTotal
capitalpremiumvaluationand loss
reserveaccount
£ £ £ £ £
At 1 July 2021100- - 2,7012,801
Profit for the financial year23,095 23,095
Shares redeemed(99)(99)
At 30 June 20231 - - 25,796 25,797
At 1 July 20231- - 25,79625,797
Profit for the financial year(20,412)(20,412)
At 30 June 20241- - 5,3845,385
UDC Health Limited
Notes to the Accounts
for the year ended 30 June 2024
1Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildingsover 50 years
Leasehold land and buildingsover the lease term
Plant and machineryover 5 years
Fixtures, fittings, tools and equipmentover 5 years
Investments
Investments in unquoted equity instruments are measured at fair value. Changes in fair value are recognised in profit or loss. Fair value is estimated by using a valuation technique.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Leased assets
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2Employees2024 2023
NumberNumber
Average number of persons employed by the company21
3Tangible fixed assets
Plant and machinery etcMotor vehiclesTotal
£ £ £
Cost
At 1 July 20231,126- 1,126
Additions- 42,42842,428
At 30 June 20241,12642,42843,554
Depreciation
At 1 July 2023203- 203
Charge for the year1667,6377,803
At 30 June 20243697,6378,006
Net book value
At 30 June 202475734,79135,548
At 30 June 2023923- 923
[For revalued assets, state the years in which the assets were valued and their values. For assets revalued during the reporting period, state the names of the persons who revalued them or particulars of their qualifications for doing so and the bases of valuation used by them.]
4Debtors2024 2023
£ £
Trade debtors16,5658,220
Other Debtors5,5101,400
Director's Account2,432-
24,5079,620
5Creditors: amounts falling due within one year2024 2023
£ £
Trade creditors27,41716
Corporation tax905,417
Other taxes and social security costs4051,625
Other Creditors2,0883,489
30,00010,547
6Creditors: amounts falling due after one year2024 2023
£ £
Bank loans28,35130,455
7Other information
UDC Health Limited is a private company limited by shares and incorporated in England. Its registered office is:
151 West Green Road
LONDON
N15 5EA
UDC Health Limited
Detailed profit and loss account
for the year ended 30 June 2024
2024 2023
£ £
Sales70,85372,240
Administrative expenses(41,397)(42,959)
Operating profit29,45629,281
Profit on the disposal of investments(49,500)-
Interest payable(368)(769)
(Loss)/profit before tax(20,412)28,512
UDC Health Limited
Detailed profit and loss account
for the year ended 30 June 2024
2024 2023
£ £
Sales
Sales70,853 72,240
Administrative expenses
Employee costs:
Wages and salaries
13,587
7,060
Directors' salaries
12,950
16,696
Pensions
220
88
Employer's NI
527
1,613
Travel and subsistence
962
1,460
Motor expenses
252
-
28,498 26,917
General administrative expenses:
Telephone and fax
240
240
Postage
47
49
Stationery and printing
154
43
Website
528
4,236
Subscriptions
78
287
Bank charges
163
214
Insurance
791
333
Equipment expensed
1,994
431
Depreciation
7,803
203
Insurance - Public Liability
161
-
11,959 6,036
Legal and professional costs:
Accountancy fees
850
990
Consultancy fees-
9,000
Other legal and professional
90
16
940 10,006
41,397 42,959
UDC Health Limited10755143false2023-07-012024-06-302024-06-30VT Final AccountsApril 2024true107551432022-07-012023-06-3010755143core:ShareCapital2022-07-012023-06-3010755143core:WithinOneYear2023-06-3010755143core:AfterOneYear2023-06-3010755143core:ShareCapital2023-06-3010755143core:RetainedEarningsAccumulatedLosses2023-06-30107551432022-06-3010755143core:ShareCapital2022-06-3010755143core:SharePremium2022-06-3010755143core:OtherReservesSubtotal2022-06-3010755143core:RetainedEarningsAccumulatedLosses2022-06-30107551432023-07-012024-06-3010755143bus:PrivateLimitedCompanyLtd2023-07-012024-06-3010755143bus:AuditExemptWithAccountantsReport2023-07-012024-06-3010755143bus:Director12023-07-012024-06-3010755143core:RetainedEarningsAccumulatedLosses2023-07-012024-06-301075514312023-07-012024-06-301075514322023-07-012024-06-3010755143core:PlantMachinery2023-07-012024-06-3010755143core:Vehicles2023-07-012024-06-3010755143countries:England2023-07-012024-06-3010755143bus:FRS1022023-07-012024-06-3010755143bus:FullAccounts2023-07-012024-06-30107551432024-06-3010755143core:WithinOneYear2024-06-3010755143core:AfterOneYear2024-06-3010755143core:ShareCapital2024-06-3010755143core:RetainedEarningsAccumulatedLosses2024-06-3010755143core:SharePremium2024-06-3010755143core:OtherReservesSubtotal2024-06-3010755143core:PlantMachinery2024-06-3010755143core:Vehicles2024-06-30107551432023-06-3010755143core:SharePremium2023-06-3010755143core:OtherReservesSubtotal2023-06-3010755143core:PlantMachinery2023-06-3010755143core:Vehicles2023-06-30iso4217:GBPxbrli:pure